OncoSil Medical LtdASX: OSL

Clarification Of Non-Renouncable Entitlement Offer Details

· Issued by OncoSil Medical Ltd

Filed with ASX · · 10 pages · English

Sydney, Australia – 2 May 2022: OncoSil Medical Ltd (ASX: OSL) (OncoSil or the Company) is responding to numerous queries from shareholders in relation to the upcoming Non-Renounceable Entitlement Offer (Offer) by providing a summary of the key dates for the Offer and other important information. Authorisation & Additional Information This announcement was authorised by the Board of Directors of O

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases